» Articles » PMID: 29455928

Transcriptional Regulation of the Warburg Effect in Cancer by SIX1

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2018 Feb 20
PMID 29455928
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Aerobic glycolysis (the Warburg effect) facilitates tumor growth, and drugs targeting aerobic glycolysis are being developed. However, how the Warburg effect is directly regulated is largely unknown. Here we show that transcription factor SIX1 directly increases the expression of many glycolytic genes, promoting the Warburg effect and tumor growth in vitro and in vivo. SIX1 regulates glycolysis through HBO1 and AIB1 histone acetyltransferases. Cancer-related SIX1 mutation increases its ability to promote aerobic glycolysis and tumor growth. SIX1 glycolytic function is directly repressed by microRNA-548a-3p, which is downregulated, inversely correlates with SIX1, and is a good predictor of prognosis in breast cancer patients. Thus, the microRNA-548a-3p/SIX1 axis strongly links aerobic glycolysis to carcinogenesis and may become a promising cancer therapeutic target.

Citing Articles

Expression patterns of MCM8 in lung adenocarcinoma and its correlation with key biological processes.

Liu X, Xie J, Wu R, Xiao G, Zhang Y, Pei Z Eur J Med Res. 2025; 30(1):149.

PMID: 40033404 PMC: 11874120. DOI: 10.1186/s40001-025-02407-8.


Transcription factor ONECUT3 regulates HDAC6/HIF-1α activity to promote the Warburg effect and tumor growth in colorectal cancer.

Huo R, Li W, Wu H, He K, Wang H, Zhang S Cell Death Dis. 2025; 16(1):149.

PMID: 40032849 PMC: 11876336. DOI: 10.1038/s41419-025-07457-8.


"Friends or foes": a new perspective of tumour metabolic transcriptional modification.

Shi T, Geng Q, Wang Z, Wen C, Xu J, Jiao Y Cell Death Dis. 2025; 16(1):106.

PMID: 39962057 PMC: 11833121. DOI: 10.1038/s41419-025-07429-y.


Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer.

Shen C, Suo Y, Guo J, Su W, Zhang Z, Yang S Front Immunol. 2025; 15:1430583.

PMID: 39867879 PMC: 11757262. DOI: 10.3389/fimmu.2024.1430583.


Targeting KAT7 inhibits the progression of colorectal cancer.

Wang H, Guan T, Hu R, Huang Z, Liang Z, Lin X Theranostics. 2025; 15(4):1478-1495.

PMID: 39816686 PMC: 11729548. DOI: 10.7150/thno.106085.